LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 128

Search options

  1. Article ; Online: Phytochemicals: Do They Belong on our Plate for Sustaining Healthspan?

    Fahey, Jed W / Kensler, Thomas W

    Food frontiers

    2021  Volume 2, Issue 3, Page(s) 235–239

    Language English
    Publishing date 2021-05-14
    Publishing country United States
    Document type Journal Article
    ISSN 2643-8429
    ISSN (online) 2643-8429
    DOI 10.1002/fft2.81
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health Action.

    Fahey, Jed W / Kensler, Thomas W

    Frontiers in nutrition

    2021  Volume 8, Page(s) 648788

    Abstract: Broccoli sprouts are a convenient and rich source of the glucosinolate glucoraphanin, which can generate the chemopreventive agent sulforaphane through the catalytic actions of plant myrosinase or β-thioglucosidases in the gut microflora. Sulforaphane, ... ...

    Abstract Broccoli sprouts are a convenient and rich source of the glucosinolate glucoraphanin, which can generate the chemopreventive agent sulforaphane through the catalytic actions of plant myrosinase or β-thioglucosidases in the gut microflora. Sulforaphane, in turn, is an inducer of cytoprotective enzymes through activation of Nrf2 signaling, and a potent inhibitor of carcinogenesis in multiple murine models. Sulforaphane is also protective in models of diabetes, neurodegenerative disease, and other inflammatory processes, likely reflecting additional actions of Nrf2 and interactions with other signaling pathways. Translating this efficacy into the design and implementation of clinical chemoprevention trials, especially food-based trials, faces numerous challenges including the selection of the source, placebo, and dose as well as standardization of the formulation of the intervention material. Unlike in animals, purified sulforaphane has had very limited use in clinical studies. We have conducted a series of clinical studies and randomized clinical trials to evaluate the effects of composition (glucoraphanin-rich [± myrosinase] vs. sulforaphane-rich or mixture beverages), formulation (beverage vs. tablet) and dose, on the efficacy of these broccoli sprout-based preparations to evaluate safety, pharmacokinetics, pharmacodynamic action, and clinical benefit. While the challenges for the evaluation of broccoli sprouts in clinical trials are themselves formidable, further hurdles must be overcome to bring this science to public health action.
    Language English
    Publishing date 2021-04-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2776676-7
    ISSN 2296-861X
    ISSN 2296-861X
    DOI 10.3389/fnut.2021.648788
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Mitigating potential public health problems associated with edible cannabis products through adequate regulation: A landscape analysis

    Soroosh, Aurash J. / Henderson, Robin / Dodson, Lori / Mitchell, Clifford S. / Fahey, Jed W.

    Critical reviews in food science and nutrition. 2021 Oct. 7, v. 61, no. 18

    2021  

    Abstract: An edible cannabis product (ECP) manufactured with food ingredients is subject to the same types of contamination as any conventional food product. Physical, microbial, and chemical hazards are a potential threat to anyone consuming cannabinoid- ... ...

    Abstract An edible cannabis product (ECP) manufactured with food ingredients is subject to the same types of contamination as any conventional food product. Physical, microbial, and chemical hazards are a potential threat to anyone consuming cannabinoid-containing products by mouth. Preventing the unintentional ingestion of ECPs is also a concern for public health professionals. An analysis of the regulatory landscape in the United States (US) was conducted to identify best practices specific to ECPs and to pinpoint preventative safety measures that had not been extensively implemented. Widespread adoption of some of the more useful precedents set by US jurisdictions, as examined in this work, could be of great value in protecting public health.
    Keywords food science ; foods ; ingestion ; landscapes ; mouth ; nutrition ; public health
    Language English
    Dates of publication 2021-1007
    Size p. 3091-3099.
    Publishing place Taylor & Francis
    Document type Article
    ZDB-ID 1037504-1
    ISSN 1549-7852 ; 1040-8398
    ISSN (online) 1549-7852
    ISSN 1040-8398
    DOI 10.1080/10408398.2020.1793099
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Crucifers and related vegetables and supplements for neurologic disorders: what is the evidence?

    Panjwani, Anita A / Liu, Hua / Fahey, Jed W

    Current opinion in clinical nutrition and metabolic care

    2018  Volume 21, Issue 6, Page(s) 451–457

    Abstract: Purpose of review: Neurologic disorders have varied pathophysiology, yet many of them appear to have core molecular pathways that are aberrant. We review the evidence that a dietary component may have utility in ameliorating or preventing at least some ... ...

    Abstract Purpose of review: Neurologic disorders have varied pathophysiology, yet many of them appear to have core molecular pathways that are aberrant. We review the evidence that a dietary component may have utility in ameliorating or preventing at least some of them.
    Recent findings: The weight of evidence supporting prescriptive dietary recommendations to promote or enhance healthspan has been building for decades. Cruciferous vegetables are a key part of the arsenal of nutrition-based approaches for reducing the burden of chronic disease. Much new evidence suggests that neurological disorders are among the potential targets for this approach. This evidence includes at least nine clinical studies of neurodevelopmental conditions like autism spectrum disorder and schizophrenia, and there are a great many studies in animal model systems, of neurodegenerative disorders like Alzheimer's and Parkinson's diseases. This review highlights the most bioactive and most well-studied compounds from crucifers - the isothiocyanates, in particular sulforaphane.
    Summary: There is great promise for the regular use of cruciferous vegetables or supplements containing standardized levels of bioactives in the treatment and prevention of neurologic disorders. Many clinical and animal studies are underway, and the evidence is building to support this strategy.
    MeSH term(s) Brassicaceae/chemistry ; Diet/methods ; Dietary Supplements ; Humans ; Isothiocyanates ; Nervous System Diseases/prevention & control ; Vegetables
    Chemical Substances Isothiocyanates ; sulforaphane (GA49J4310U)
    Language English
    Publishing date 2018-08-23
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1460178-3
    ISSN 1473-6519 ; 1363-1950
    ISSN (online) 1473-6519
    ISSN 1363-1950
    DOI 10.1097/MCO.0000000000000511
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Mitigating potential public health problems associated with edible cannabis products through adequate regulation: A landscape analysis.

    Soroosh, Aurash J / Henderson, Robin / Dodson, Lori / Mitchell, Clifford S / Fahey, Jed W

    Critical reviews in food science and nutrition

    2020  Volume 61, Issue 18, Page(s) 3091–3099

    Abstract: An edible cannabis product (ECP) manufactured with food ingredients is subject to the same types of contamination as any conventional food product. Physical, microbial, and chemical hazards are a potential threat to anyone consuming cannabinoid- ... ...

    Abstract An edible cannabis product (ECP) manufactured with food ingredients is subject to the same types of contamination as any conventional food product. Physical, microbial, and chemical hazards are a potential threat to anyone consuming cannabinoid-containing products by mouth. Preventing the unintentional ingestion of ECPs is also a concern for public health professionals. An analysis of the regulatory landscape in the United States (US) was conducted to identify best practices specific to ECPs and to pinpoint preventative safety measures that had not been extensively implemented. Widespread adoption of some of the more useful precedents set by US jurisdictions, as examined in this work, could be of great value in protecting public health.
    MeSH term(s) Cannabis ; Commerce ; Eating ; Food ; Public Health ; United States
    Language English
    Publishing date 2020-08-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1037504-1
    ISSN 1549-7852 ; 1040-8398
    ISSN (online) 1549-7852
    ISSN 1040-8398
    DOI 10.1080/10408398.2020.1793099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Health span extension through green chemoprevention.

    Fahey, Jed W / Kensler, Thomas W

    The virtual mentor : VM

    2013  Volume 15, Issue 4, Page(s) 311–318

    MeSH term(s) Anticarcinogenic Agents ; Chemoprevention ; Diet ; Health Behavior ; Humans ; Life Style ; Longevity ; Neoplasms/prevention & control ; Plant Preparations ; Preventive Medicine/methods
    Chemical Substances Anticarcinogenic Agents ; Plant Preparations
    Language English
    Publishing date 2013
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 1937-7010
    ISSN (online) 1937-7010
    DOI 10.1001/virtualmentor.2013.15.4.stas1-1304
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Correction to: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.

    Zimmerman, Andrew W / Singh, Kanwaljit / Connors, Susan L / Liu, Hua / Panjwani, Anita A / Lee, Li-Ching / Diggins, Eileen / Foley, Ann / Melnyk, Stepan / Singh, Indrapal N / Jill James, S / Frye, Richard E / Fahey, Jed W

    Molecular autism

    2021  Volume 12, Issue 1, Page(s) 44

    Language English
    Publishing date 2021-06-16
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2540930-X
    ISSN 2040-2392 ; 2040-2392
    ISSN (online) 2040-2392
    ISSN 2040-2392
    DOI 10.1186/s13229-021-00451-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Isothiocyanates: Translating the Power of Plants to People.

    Palliyaguru, Dushani L / Yuan, Jian-Min / Kensler, Thomas W / Fahey, Jed W

    Molecular nutrition & food research

    2018  Volume 62, Issue 18, Page(s) e1700965

    Abstract: Isothiocyanates from cruciferous vegetables have been studied extensively in cells and in animals for their disease preventive and therapeutic effects. However, translating their utility to human populations has been both limited and challenging. Herein, ...

    Abstract Isothiocyanates from cruciferous vegetables have been studied extensively in cells and in animals for their disease preventive and therapeutic effects. However, translating their utility to human populations has been both limited and challenging. Herein, clinical trials employing two isothiocyanates, sulforaphane (SFN; 1-isothiocyanato-4-(methylsulfinyl) butane) and phenethyl isothiocyanate (PEITC; 2-isothiocyanatoethylbenzene) that are isolated principally from broccoli and watercress, respectively, are summarized and discussed. Both of these compounds have been used in small human clinical trials, either within food matrices or as single agents, against a variety of diseases ranging from cancer to autism. Results suggest an opportunity to incorporate them, or more likely preparations derived from their source plants, into larger human disease mitigation efforts. The context for the applications of these compounds and plants in evidence-based food and nutritional policy is also evaluated.
    MeSH term(s) Brassica/chemistry ; Cardiovascular Diseases/drug therapy ; Clinical Trials as Topic ; Diabetes Mellitus, Type 2/drug therapy ; Humans ; Isothiocyanates/chemistry ; Isothiocyanates/pharmacology ; Neoplasms/drug therapy ; Skin Diseases/drug therapy ; Sulfoxides ; Treatment Outcome ; Vegetables/chemistry
    Chemical Substances Isothiocyanates ; Sulfoxides ; phenethyl isothiocyanate (6U7TFK75KV) ; sulforaphane (GA49J4310U)
    Language English
    Publishing date 2018-03-26
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2160372-8
    ISSN 1613-4133 ; 1613-4125
    ISSN (online) 1613-4133
    ISSN 1613-4125
    DOI 10.1002/mnfr.201700965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Broccoli or Sulforaphane: Is It the Source or Dose That Matters?

    Yagishita, Yoko / Fahey, Jed W / Dinkova-Kostova, Albena T / Kensler, Thomas W

    Molecules (Basel, Switzerland)

    2019  Volume 24, Issue 19

    Abstract: There is robust epidemiological evidence for the beneficial effects of broccoli consumption on health, many of them clearly mediated by the isothiocyanate sulforaphane. Present in the plant as its precursor, glucoraphanin, sulforaphane is formed through ... ...

    Abstract There is robust epidemiological evidence for the beneficial effects of broccoli consumption on health, many of them clearly mediated by the isothiocyanate sulforaphane. Present in the plant as its precursor, glucoraphanin, sulforaphane is formed through the actions of myrosinase, a β-thioglucosidase present in either the plant tissue or the mammalian microbiome. Since first isolated from broccoli and demonstrated to have cancer chemoprotective properties in rats in the early 1990s, over 3000 publications have described its efficacy in rodent disease models, underlying mechanisms of action or, to date, over 50 clinical trials examining pharmacokinetics, pharmacodynamics and disease mitigation. This review evaluates the current state of knowledge regarding the relationships between formulation (e.g., plants, sprouts, beverages, supplements), bioavailability and efficacy, and the doses of glucoraphanin and/or sulforaphane that have been used in pre-clinical and clinical studies. We pay special attention to the challenges for better integration of animal model and clinical studies, particularly with regard to selection of dose and route of administration. More effort is required to elucidate underlying mechanisms of action and to develop and validate biomarkers of pharmacodynamic action in humans. A sobering lesson is that changes in approach will be required to implement a public health paradigm for dispensing benefit across all spectrums of the global population.
    MeSH term(s) Animals ; Anti-Infective Agents/chemistry ; Anti-Infective Agents/pharmacokinetics ; Anti-Infective Agents/therapeutic use ; Antineoplastic Agents, Phytogenic/chemistry ; Antineoplastic Agents, Phytogenic/pharmacokinetics ; Antineoplastic Agents, Phytogenic/therapeutic use ; Biomarkers, Tumor/metabolism ; Brassica/chemistry ; Clinical Trials as Topic ; Humans ; Isothiocyanates/chemistry ; Isothiocyanates/pharmacokinetics ; Isothiocyanates/therapeutic use ; Molecular Structure ; Plant Extracts/chemistry ; Sulfoxides
    Chemical Substances Anti-Infective Agents ; Antineoplastic Agents, Phytogenic ; Biomarkers, Tumor ; Isothiocyanates ; Plant Extracts ; Sulfoxides ; sulforaphane (GA49J4310U)
    Language English
    Publishing date 2019-10-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules24193593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Broccoli or Sulforaphane

    Yoko Yagishita / Jed W. Fahey / Albena T. Dinkova-Kostova / Thomas W. Kensler

    Molecules, Vol 24, Iss 19, p

    Is It the Source or Dose That Matters?

    2019  Volume 3593

    Abstract: There is robust epidemiological evidence for the beneficial effects of broccoli consumption on health, many of them clearly mediated by the isothiocyanate sulforaphane. Present in the plant as its precursor, glucoraphanin, sulforaphane is formed through ... ...

    Abstract There is robust epidemiological evidence for the beneficial effects of broccoli consumption on health, many of them clearly mediated by the isothiocyanate sulforaphane. Present in the plant as its precursor, glucoraphanin, sulforaphane is formed through the actions of myrosinase, a β-thioglucosidase present in either the plant tissue or the mammalian microbiome. Since first isolated from broccoli and demonstrated to have cancer chemoprotective properties in rats in the early 1990s, over 3000 publications have described its efficacy in rodent disease models, underlying mechanisms of action or, to date, over 50 clinical trials examining pharmacokinetics, pharmacodynamics and disease mitigation. This review evaluates the current state of knowledge regarding the relationships between formulation (e.g., plants, sprouts, beverages, supplements), bioavailability and efficacy, and the doses of glucoraphanin and/or sulforaphane that have been used in pre-clinical and clinical studies. We pay special attention to the challenges for better integration of animal model and clinical studies, particularly with regard to selection of dose and route of administration. More effort is required to elucidate underlying mechanisms of action and to develop and validate biomarkers of pharmacodynamic action in humans. A sobering lesson is that changes in approach will be required to implement a public health paradigm for dispensing benefit across all spectrums of the global population.
    Keywords broccoli ; sulforaphane ; glucoraphanin ; myrosinase ; chemoprotection ; allometric scaling ; clinical trials ; nrf2 ; toxicity ; Organic chemistry ; QD241-441
    Subject code 610
    Language English
    Publishing date 2019-10-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top